Autoinflammatory & rare systemic diseases

Association between biologic exposure and relapse incidence in relapsing polychondritis: a retrospective cohort study

Rheumatology (Oxford)Published Retrospective cohort study

Authors' conclusion

Biologic exposure was associated with lower relapse rates than during No-Bio periods in relapsing polychondritis, whereas estimates for hospitalized infection were imprecise.

Study context

Population
Adults with relapsing polychondritis, Kyoto University Hospital, 2000–23
Participants
55 adults503.5 person-years
Exposure
Periods with TNFi or IL-6Ri vs periods without biologics
Outcome
Primary outcomes: relapsing polychondritis relapse and hospitalized infection
Methodological detailssingle-centre, negative binomial regression with log(person-time) offset, regression standardization
  • Single-centre
  • Negative binomial regression with log(person-time) offset
  • Regression standardization

Main finding

As reported in the abstract

Relapse
Each group vs No-BioIncidence rate ratio (95% CI)
TNFiadjusted
0.4(0.2–0.8)
IL-6Riadjusted
0.2(0.1–0.4)
Each group vs No-BioAdjusted rate difference, events per 100 person-years (95% CI)
TNFi
−54.0(−141.5 to −5.5)
IL-6Ri
−68.3(−149.8 to −21.4)

Observational data: associations, not effects.

Safety

OutcomeIRR (95% CI)
Hospitalized infection (co-primary)TNFivs No-BioEstimates imprecise0.3 (0.1–1.4)
Hospitalized infection (co-primary)IL-6Rivs No-BioEstimates imprecise0.7 (0.2–2.6)

Original publication

Association between biologic exposure and relapse incidence in relapsing polychondritis: a retrospective cohort study. Rheumatology (Oxford). Published 11 June 2026. doi:10.1093/rheumatology/keag305

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.